San Jose State University

SJSU ScholarWorks
Faculty Publications

Health Science and Recreation

1-2002

Cigarette smoking and the desire to quit among individuals living
with HIV
Edward M. Mamary
San Jose State University, edward.mamary@sjsu.edu

Darlene Bahrs
San Francisco Department of Health

Sharon Martinez
University of California - San Francisco

Follow this and additional works at: https://scholarworks.sjsu.edu/healthsci_rec_pub
Part of the Medicine and Health Sciences Commons

Recommended Citation
Edward M. Mamary, Darlene Bahrs, and Sharon Martinez. "Cigarette smoking and the desire to quit among
individuals living with HIV" AIDS Patient Care and STDs (2002): 39-42. https://doi.org/10.1089/
108729102753429389

This Article is brought to you for free and open access by the Health Science and Recreation at SJSU
ScholarWorks. It has been accepted for inclusion in Faculty Publications by an authorized administrator of SJSU
ScholarWorks. For more information, please contact scholarworks@sjsu.edu.

AIDS PATIENT CARE and STDs
Volume 16, Number 1, 2002
Mary Ann Liebert, Inc.

Cigarette Smoking and the Desire to Quit Among
Individuals Living with HIV
EDWARD M. MAMARY, Dr.P.H., M.S.,1 DARLENE BAHRS, M.A., M.P.H.,2
and SHARON MARTINEZ, B.A.3

ABSTRACT
Among individuals living with human immunodeficiency virus (HIV), studies have found that
smokers are at greater risk than nonsmokers to develop bacterial pneumonia, oral lesions and
acquired immune deficiency syndrome (AIDS) dementia complex. Information is lacking re
garding the prevalence of cigarette smoking among people living with HIV or about their in
tentions to quit smoking. A survey was conducted with a sample of patients attending an HIV
outpatient clinic at San Francisco General Hospital to assess the prevalence of cigarette smok
ing and the level of interest in quitting. In total, 228 assessments were completed. Study re
sults revealed a high percentage of smokers among our sample of individuals living with HIV
compared to the percentage of smokers found in the general adult population. A total of 123
individuals (54%) reported that they smoked cigarettes. Men were more than twice as likely
to have made previous attempts at smoking cessation than were woman. The majority of cig
arette smokers (63%) reported that they were currently thinking about quitting. Respondents’
preferences for types of smoking cessation methods are discussed, and recommendations are
proposed for identifying and treating tobacco dependence in this population.

smokers to develop bacterial pneumonia, oral
lesions and acquired immunodeficiency syndrome (AIDS) dementia complex.2–4 The progression of smoking-induced emphysema is
hastened in individuals with HIV infection as
well.5 Increased rates of lung cancer among individuals living with HIV/AIDS appear to be
attributed to smoking rather than immunosuppression. 6
Of the estimated 70% of cigarette smokers in
the general adult U.S. population who reported
visiting a physician or other health care professional at least once within the preceding 12
months, only 37% reported having received ad-

INTRODUCTION

I

N THE GENERAL POPULATION , cigarette smoking has been associated with increased rates
of morbidity, specifically with increased risk of
cancer, coronary heart disease, stroke, respiratory infections, and chronic lung disease. More
than 430,000 U.S. deaths each year are attributable to tobacco use, with an economic burden of at least $50 billion for medical expenditures and another $50 billion in indirect costs.1
Among individuals living with human immunodeficiency virus (HIV), studies have
found that smokers are at greater risk than non-
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vice from their health care provider to quit
smoking.7 This finding suggests that a significant number of opportunities are missed by
health care professionals to advise their patients to quit smoking, despite the fact that
smoking cessation has been shown to be clinically successful and cost effective.8
In the general population, smoking prevalence and cessation success rates vary among
minority subgroups of the population.8 While
little is known about the prevalence of cigarette
smoking among people living with HIV or
about their intentions to quit smoking, there
has been speculation that this group might lack
motivation to quit, because of a pessimistic
view of the likelihood of long-term survival.
Moreover, clinicians who hold similarly unhopeful views might be less likely to recommend smoking cessation to their patients living with HIV, even though current research
indicates that HIV patients can benefit from
quitting.9 Physicians, too, could be reluctant to
prescribe nicotine replacement, not wishing to
add a further burden to an already complicated
and cumbersome medical regimen.
The advent of new antiretroviral treatments
has decreased AIDS-related morbidity and mortality dramatically.10 For the most part, the focus of primary care delivery has moved from
treating HIV disease as a terminal illness to developing treatment strategies to manage HIV as
a chronic condition.11 For many, improved management of HIV disease has fostered a more optimistic outlook for long-term survival and provided a basis for seeking general improvement
in the quality of life, which in turn has offered
motivation to quit smoking. Improved
prospects for HIV patients have also provided
the impetus for clinicians to recommend smoking abstinence and cessation programs to individuals living with HIV. This paper describes
the results of a survey that assessed the prevalence of cigarette smoking and the level of interest in quitting among a sample of patients attending an HIV outpatient clinic at San
Francisco General Hospital (SFGH).

ments at the clinic during a 3-week period in
1998. The total number of unduplicated HIV
patients receiving care at the clinic during 1998
was, 2421, with a majority of them being male
(84%). Although data on HIV risk factors for
the overall patient population were not available through the clinic, a breakdown by HIV
risk category for clinic patients living with an
AIDS diagnosis was available through Department of Public Health AIDS Office internal surveillance reports (L. Hsu, personal communication, 2001) as follows: males who have sex
with males (64%), males who have sex with
males and who are also injection drug users
(18%), males who are injection drug users (9%),
females who are injection drug users (5%), females who have sex with males (2%), other/unknown risk for males (,1%) and other/unknown risk for females (, 1%).
In order to encourage clinicians to complete
the smoking assessment with their patients, a
questionnaire was attached to the cover of each
medical record prior to the patient’s scheduled
clinic appointment. To ease the time commitment of clinicians during patient visits, the
questionnaire was brief and contained only
nine short, closed-end questions with only a
few response options. First, patients were
asked if they smoked cigarettes. Those individuals who identified themselves as smokers
were then asked about their smoking behavior
in terms of frequency, length of time smoking,
and number of previous cessation attempts.
Participants were also asked whether they
were thinking about quitting. Among those
who indicated that they wished to quit smoking, clinicians assessed levels of interest in
group programs for smoking cessation and/or
nicotine replacement treatments. Data were
compiled and entered into a database, without
identifying information, by the clinic’s health
education coordinator. SPSS for Windows
(Version 10) was the statistical package used
for data analysis.

RESULTS
MATERIALS AND METHODS
A survey was administered by clinicians to
HIV patients attending scheduled appoint-

A total of 228 assessments were completed.
The average age of respondents was 40 years old
(range, 22–71). A total of 123 individuals (54%)
reported that they smoked cigarettes. Charac-
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teristics of smokers are reported in Table 1. Most
of the smokers were men (83%). Smokers reported that they had smoked for many years
(mean, 21.8 years), with men reporting an average of one pack of cigarettes per day and women
reporting an average of three-quarters of a pack
of cigarettes per day. The majority of smokers
(72%) reported that they had tried to quit smoking previously. The proportion of men (81%)
who reported previous cessation attempts was
twice that of woman (40%), with the difference
being statistically significant (x2 (1, N 5 116) 5
14.68, p 5 ,0.001). The majority of smokers
(63%) reported that they were currently thinking about quitting, with no significant difference
found between men and women. Of those respondents thinking about quitting, 69% expressed interest in participating in a group
smoking cessation program, while 82% indicated interest in receiving a prescription for a
nicotine replacement medication. A majority of
smokers considering cessation (56%) reported
that they were interested in both group intervention and nicotine replacement.

DISCUSSION
Study results revealed a high percentage of
smokers among our sample of individuals living with HIV compared to the percentage of
smokers found in the general adult population.
The percentage of smokers in the study sample
(54%) was three times that of the general adult
populations of the City and County of San Francisco (18%)12 and the State of California
(18%).13,14 Consistent with the smoking cessation literature,15 our data reveal that most cigarette smokers had previously attempted smoking cessation. Men in this study were more than

TABLE 1.

CHARACTERISTICS

Gender (%)a
Mean age in years
Average # years
smoking
Mean # of cigarette
packs/day
a Percentages

OF

HIV-POSITIVE SMOKERS

Male

Female

Combined

83.3
40.2
21.2

16.7
42.2
26.1

40.5
21.8

1.0

.75

.95

do not include three respondents for
whom gender was not recorded.

twice as likely to have attempted smoking cessation than woman. Therefore, because a history
of previous attempts at quitting has been found
to be a predictor of smoking relapse,16 men may
require additional follow-up to improve their
long-term abstinence from smoking.
Contrary to what has been suggested in the
literature, our data reveal that the majority of
cigarette smokers living with HIV mirror their
counterparts in the general population of the
United States population in the desire to quit
smoking. Furthermore, most respondents were
interested in obtaining assistance and expressed
willingness to use a combination of smoking
cessation methods, including nicotine replacement and participation in a group intervention.
This is encouraging, since the use of a combination of smoking cessation methods (as compared to one method alone) increases the likelihood of long-term success rates.8 Moreover, it is
plausible that those who reported a motivation
to quit smoking did so as a result of an increased
optimism regarding their longevity and the general quality of their lives.
Limitations of the study included self-reported
data, in which the accuracy of smoking status
could not be verified and the unavailability of
specific data (because of confidentiality concerns) that would have allowed for a comparison of smoking prevalence based on key variables, such as sexual orientation and drug use.

CONCLUSION
As with the general population and in accordance with the current clinical guideline for
identifying and treating tobacco dependence
recommended by the U.S. Department of Health
and Human Services (DHHS),8 clinicians treating HIV patients should assess tobacco use and
document the results at every clinic visit. As the
availability of effective HIV treatments continues to increase, the number of HIV patients who
seek medical care will also increase,17 which
should give provides more opportunities to
identify individuals who smoke. In accordance
with the DHHS guideline, once smokers are
identified, clinicians should first advise their patients to quit and then assess their willingness
to do so. Given time constraints, clinicians
should be trained in techniques for conducting
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brief interventions, using a combination of counseling and pharmacotherapy to help their patients quit smoking. Follow-up contacts should
be part of a protocol that addresses the possibility of relapses. Efforts to train physicians in
this area will contribute to meeting one of the
objectives of the Nation’s Healthy People 2010,
to increase the proportion of physicians who
counsel their patients to stop using tobacco.18 In
light of the evidence indicating that more intensive treatments (such as those used in multiple
group session interventions) produce greater
success rates,8 patients needing more intensive
treatment should be referred to reputable smoking cessation programs such as those offered by
the American Lung Association. However, established programs would be well advised to
address the unique concerns of individuals living with HIV by adapting to their special circumstances. For example, focus groups conducted with cigarette smokers living with HIV
revealed that participants preferred group interventions comprised exclusively of HIV positive individuals.19
Evidence supports that even very brief
smoking cessation interventions, lasting less
than 3 minutes, can have a positive impact on
overall abstinence rates.8 Considering the high
prevalence of cigarette smoking found in this
study sample of HIV patients, it is incumbent
upon health care professionals to promote
smoking cessation as part of the routine delivery of health care services to this particularly
vulnerable population.
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